Clinical Trial

Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels

Study acronym: OMAGOD-1
Completed
View on ClinicalTrials.gov →
Summary
Individuals with ESKD and treated with hemodialysis have a high mortality risk. Associative studies suggest a relationship between serum magnesium concentration and mortality risk. The influence of magnesium concentration on mortality risk is unknown. This pilot study will explore whether altering dialysate magnesium concentration in the presence of citrate will change serum magnesium concentrations.
Trial Details
NCT Number NCT07565779
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Collaborators: Fresenius AG
Conditions Dialysis; Complications
Enrollment 54 participants
Start Date 2025-01-28
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04